Lin Zhenhua, Kim Hankyeom, Park Hongseok, Kim Youngsik, Cheon Jun, Kim Insun
Department of Pathology and Urology, Korea University Medicine College, 126-1, 5 Ga, Anam Dong, Sungbuk Gu, Seoul, Korea.
Urol Res. 2003 Aug;31(4):272-5. doi: 10.1007/s00240-003-0324-3. Epub 2003 Jul 16.
The bcl-2 proto-oncogene plays a key role in cell longevity by preventing apoptosis. Bcl-2 is important in developing and maintaining the normal function of lymphoid and epithelial tissues. The bcl-6 protein is a 96 kDa nuclear protein selectively expressed in mature B cells within normal germinal centers as well as in their transformed counterparts in diffuse large B cell lymphoma. Recently, the bcl-6 protein has also been reported to be expressed in normal skin and epidermal neoplasms. In this study, 47 cases of transitional cell carcinomas (TCCs) were immunohistochemically studied for bcl-2 and bcl-6 protein expression. The results showed that bcl-2 was expressed only on basal layer cells, whereas bcl-6 expression was restricted to the superficial layers in the normal transitional epithelium. Von Brunn's nests showed strong immunostaining to bcl-2, but were negative to bcl-6. Among 47 TCCs, 15 (32.6%) and 29 (61.7%) cases were positive for bcl-2 and bcl-6, respectively. Compared with the normal transitional epithelium, the expression of bcl-2 was significantly decreased, whereas bcl-6 expression was significantly increased in TCCs. Additionally, the strong expression of bcl-6 had a positive correlation with the histopathologic grade of TCC. In conclusion, bcl-2 and bcl-6 proteins may play a role in the pathogenesis of TCCs, and bcl-6 expression reflects histopathologic grade.
bcl-2原癌基因通过阻止细胞凋亡在细胞寿命方面发挥关键作用。Bcl-2在淋巴组织和上皮组织的发育及维持正常功能中很重要。bcl-6蛋白是一种96 kDa的核蛋白,在正常生发中心的成熟B细胞以及弥漫性大B细胞淋巴瘤中其转化对应物中选择性表达。最近,据报道bcl-6蛋白也在正常皮肤和表皮肿瘤中表达。在本研究中,对47例移行细胞癌(TCC)进行了bcl-2和bcl-6蛋白表达的免疫组织化学研究。结果显示,bcl-2仅在基底层细胞表达,而bcl-6表达局限于正常移行上皮的表层。冯·布伦巢对bcl-2呈强免疫染色,但对bcl-6呈阴性。在47例TCC中,分别有15例(32.6%)和29例(61.7%)bcl-2和bcl-6呈阳性。与正常移行上皮相比,TCC中bcl-2的表达显著降低,而bcl-6表达显著增加。此外,bcl-6的强表达与TCC的组织病理学分级呈正相关。总之,bcl-2和bcl-6蛋白可能在TCC的发病机制中起作用,且bcl-6表达反映组织病理学分级。